London Daily

Focus on the big picture.
Tuesday, Jul 29, 2025

Women in England almost twice as likely as men to be prescribed opiate painkillers

Women in England almost twice as likely as men to be prescribed opiate painkillers

Experts worried about high use of drugs such as codeine and tramadol after prescriptions rose during Covid pandemic
Women in England are almost twice as likely as men to be prescribed powerful and potentially addictive opiate painkillers, prompting experts to warn that female pain is overly medicated and not properly investigated.

The number of people prescribed drugs such as codeine and tramadol – often used for chronic pain – rose to 1.18 million in the first 10 months of 2020. Of these, 745,047 were women and 434,697 were men, a Guardian analysis found.

The growth in such prescriptions issued to women rose by 4.5% between October 2015 and October 2020, compared with an increase of less than 1% for men. Annual averages showed the same trend, according to data from the NHS Business Services Authority, which deals with prescription services in England.

It comes after figures showed deaths from prescription opioid painkillers have doubled from 350 to 700 over the past decade. These drugs are usually prescribed for severe pain, for example after an operation or a serious injury.

Guidance issued by the National Institute for Health and Care Excellence (Nice) this month said people with chronic pain which had no known cause should not be prescribed painkillers, and should instead be offered therapies including exercise programmes, acupuncture and antidepressants. There was “little or no evidence” that treating chronic primary pain – which affects 1-6% of people in England – with commonly used painkillers actually made a difference to people’s quality of life, pain or psychological distress, Nice said.

Emma Davies, a pharmacist pain practitioner at Cwm Taf Morgannwg University Health Board in Wales, said the opiate painkillers gender gap was a “worry” and called for better research into the reasons behind it. Opiate painkillers were “potentially harmful” and did not always take away pain, she said.

“From a clinician’s perspective, overprescribing is generally occurring regardless of gender and presentation. But there is a big issue with women’s services – there are not sufficient services for women’s specific health problems. That means women struggle to get diagnosed and when they do there is limited availability of suitable services.”

Dr Emma Sheppard, a sociologist at Coventry University who researches living with chronic pain and has experienced it herself, said: “Women are diagnosed with chronic pain at a much higher rate.

“Chronic pain leads to a lower quality of life for a huge variety of reasons so being able to function with chronic pain might in effect mean being addicted to painkillers but you weigh the costs up.”

She added: “There is no known reason why women experience it more: it could be biology, it could be social or it could be the impact of particular lifestyles on bodies, or it could be environmental. The causes of chronic pain are so broad and in some cases not well understood.”

Women who contacted the Guardian said they felt “fobbed” off by painkillers and that the problems leading to their discomfort were not always properly investigated. The government is launching a review to better understand women’s experiences of the health and care system, including how pain is treated. They are creating the first-ever government-led Women’s Health Strategy, which aims to ensure health services are meeting the needs of women.

Last year, an inquiry ordered by the government found that an arrogant culture in which serious medical complications were dismissed as “women’s problems” contributed to a string of healthcare scandals over several decades.

The use of opioid drugs has been of growing concern in recent years, particularly in relation to the risk of addiction and overdose, and their limited effectiveness over time. “We are well aware opiates are overused and that is a concern for us, and as a faculty we are working to provide much better guidance to reduce overuse of opiates,” said Dr Barry Miller of the Faculty of Pain Medicine.

He said the number of women on these drugs was a concern. “I would worry about anyone on these drugs – male or female, young or old. It is an area of worry and I would not underestimate that.”

The sharp rate of increase in prescriptions has levelled out in recent years, but the total is still far higher than previously. Data shows the number of individuals issued prescriptions of “opioids” and “opioid analgesic” in October 2020 stood at 1.2 million, up 3.1% on the same period in 2015 and slightly higher than the rate of increase in population.

Ian Hamilton, an associate professor of addiction at the University of York, said that although the rise in prescriptions in the past five years was small, it was surprising given the greater “awareness among doctors about the problems with these type of drugs, ie dependency and reduced effectiveness if used for more than a few weeks”.

He said: “I think the reason more women have been prescribed these type of drugs is that they are more likely to access healthcare including their GP. We know that GPs don’t have much time and with support services declining this leaves many GPs with no option but to prescribe or continue prescribing these type of drugs, even when they know they don’t address the root cause of the problem.”

Miller said the rise in use of opiate painkillers during the pandemic could be due to people waiting longer for other treatments, such as knee and hip replacements.

Sheppard said chronic pain “may not be well understood and it may require referrals to different or other medical services and specialists” but “depending on where someone is living they may not be able to get that referral”.

Public Health England has raised concern about the number of prescription medicines administered. In a 2019 review, it said that using opiate painkillers for more than a few weeks is not supported by the evidence.

An NHS spokesperson said: “While these drugs play an important role for some people, GPs and pharmacists are working with their patients to ensure they are on the right medicines for the right reasons – for many, rather than a ‘pill for every ill’, social prescribing and talking therapies can be more appropriate ways of helping some people to get better and stay healthy.”
Newsletter

Related Articles

0:00
0:00
Close
France Opens Criminal Investigation into X Over Algorithm Manipulation Allegations
A family has been arrested in the UK for displaying the British flag
Mel Gibson refuses to work with Robert De Niro, saying, "Keep that woke clown away from me."
Trump Steamrolls EU in Landmark Trade Win: US–EU Trade Deal Imposes 15% Tariff on European Imports
ChatGPT CEO Sam Altman says people share personal info with ChatGPT but don’t know chats can be used as court evidence in legal cases.
The British propaganda channel BBC News lies again.
Deputy attorney general's second day of meeting with Ghislaine Maxwell has concluded
Controversial March in Switzerland Features Men Dressed in Nazi Uniforms
Politics is a good business: Barack Obama’s Reported Net Worth Growth, 1990–2025
Thai Civilian Death Toll Rises to 12 in Cambodian Cross-Border Attacks
TSUNAMI: Trump Just Crossed the Rubicon—And There’s No Turning Back
Over 120 Criminal Cases Dismissed in Boston Amid Public Defender Shortage
UN's Top Court Declares Environmental Protection a Legal Obligation Under International Law
"Crazy Thing": OpenAI's Sam Altman Warns Of AI Voice Fraud Crisis In Banking
The Podcaster Who Accidentally Revealed He Earns Over $10 Million a Year
Trump Announces $550 Billion Japanese Investment and New Trade Agreements with Indonesia and the Philippines
US Treasury Secretary Calls for Institutional Review of Federal Reserve Amid AI‑Driven Growth Expectations
UK Government Considers Dropping Demand for Apple Encryption Backdoor
Severe Flooding in South Korea Claims Lives Amid Ongoing Rescue Operations
Japanese Man Discovers Family Connection Through DNA Testing After Decades of Separation
Russia Signals Openness to Ukraine Peace Talks Amid Escalating Drone Warfare
Switzerland Implements Ban on Mammography Screening
Japanese Prime Minister Vows to Stay After Coalition Loses Upper House Majority
Pogacar Extends Dominance with Stage Fifteen Triumph at Tour de France
CEO Resigns Amid Controversy Over Relationship with HR Executive
Man Dies After Being Pulled Into MRI Machine Due to Metal Chain in New York Clinic
NVIDIA Achieves $4 Trillion Valuation Amid AI Demand
US Revokes Visas of Brazilian Corrupted Judges Amid Fake Bolsonaro Investigation
U.S. Congress Approves Rescissions Act Cutting Federal Funding for NPR and PBS
North Korea Restricts Foreign Tourist Access to New Seaside Resort
Brazil's Supreme Court Imposes Radical Restrictions on Former President Bolsonaro
Centrist Criticism of von der Leyen Resurfaces as she Survives EU Confidence Vote
Judge Criticizes DOJ Over Secrecy in Dropping Charges Against Gang Leader
Apple Closes $16.5 Billion Tax Dispute With Ireland
Von der Leyen Faces Setback Over €2 Trillion EU Budget Proposal
UK and Germany Collaborate on Global Military Equipment Sales
Trump Plans Over 10% Tariffs on African and Caribbean Nations
Flying Taxi CEO Reclaims Billionaire Status After Stock Surge
Epstein Files Deepen Republican Party Divide
Zuckerberg Faces $8 Billion Privacy Lawsuit From Meta Shareholders
FIFA Pressured to Rethink World Cup Calendar Due to Climate Change
SpaceX Nears $400 Billion Valuation With New Share Sale
Microsoft, US Lab to Use AI for Faster Nuclear Plant Licensing
Trump Walks Back Talk of Firing Fed Chair Jerome Powell
Zelensky Reshuffles Cabinet to Win Support at Home and in Washington
"Can You Hit Moscow?" Trump Asked Zelensky To Make Putin "Feel The Pain"
Irish Tech Worker Detained 100 days by US Authorities for Overstaying Visa
Dimon Warns on Fed Independence as Trump Administration Eyes Powell’s Succession
Church of England Removes 1991 Sexuality Guidelines from Clergy Selection
Superman Franchise Achieves Success with Latest Release
×